Illumina (Nasdaq:ILMN) announced today that it launched a new state-of-the-art solution center in São Paulo, Brazil. San Diego-based Illumina selected Brazil as a location for the facility to reflect the increasing demand for and interest in clinical genomics as it seeks to expand access to such genomics in Latin America. According to a news release, Illumina’s […]
Illumina Inc.
Illumina launches new genomic profiling test for cancer in Europe
Illumina (Nasdaq:ILMN) announced today that it launched its TruSight oncology test for assessing multiple tumor genes and biomarkers. San Diego-based Illumina’s CE-marked TruSight test, which will begin its global launch in Europe, assesses the tumor genes and biomarkers to reveal the specific molecular profile of a patient’s cancer, helping to inform precision medicine decisions. According […]
Illumina appoints chief information officer
Illumina (Nasdaq:ILMN) announced today that it appointed Carissa Rollins as its new chief information officer. A 30-year veteran of business technology transformation and digital and consumerization strategy, Rollins joins San Diego-based Illumina having most recently served as chief information officer (CIO) at UnitedHealthcare. Her appointment was made effective today. Rollins’ responsibilities at UnitedHealthcare included strategy […]
Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list
Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of […]
Medtech M&A: The industry’s biggest mergers and acquisitions of 2021
Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]
Illumina, Merck partner on diagnostics for identifying specific cancer mutations
Illumina (NSDQ:ILMN) and Merck today announced a partnership to develop diagnostics for identifying certain genetic mutations. The partnership aims to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD), leveraging Illumina’s TruSight Oncology 500 (TSO 500) content, enabling what the companies tout as the most comprehensive genomic […]
MedTech 100 roundup: Industry reaches another high point
The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. […]
EU to investigate Illumina’s decision to close $8B Grail acquisition
The European Commission announced that it opened an investigation to assess Illumina’s (NSDQ:ILMN) recently completed acquisition of Grail. Last week, Illumina completed its long-awaited, highly-scrutinized acquisition of the cancer detection company that spun out from Illumina nearly five years ago. The $8 billion acquisition was initially announced in September 2020. Within the announcement of the […]
MedTech 100 roundup: On the rise again
After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]
Illumina completes $8B Grail acquisition, companies remain separate amid European review
Illumina (NSDQ:ILMN) announced that it completed its long-awaited and much-scrutinized acquisition of cancer detection company Grail. Illumina, however, also said in a news release that it will hold Grail as a separate company as the European Commission conducts an ongoing regulatory review. A decision from the EU regulators is projected after the deal expires, but […]
MedTech 100 roundup: Rebound hits a snag
Two weeks ago, medtech was on the rise following a rough stretch, but the past week brought the industry slightly back down to earth. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 4) at 106.96 points, producing a -1.4% dip from the 108.5-point mark […]
